Literature DB >> 26522767

A t(8;9)(p22;p24)/PCM1-JAK2 translocation in a patient with myeloproliferative neoplasm and myeloid sarcoma: first report in Korea.

Ilgeun Song1, Dong Hyun Lee1, Je Hwan Lee2, Seongsoo Jang1, Joo Ryung Huh3, Eul Ju Seo4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26522767      PMCID： PMC4697351          DOI： 10.3343/alm.2016.36.1.79

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  8 in total

Review 1.  PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms.

Authors:  Sylvia Hoeller; Christoph Walz; Andreas Reiter; Stephan Dirnhofer; Alexandar Tzankov
Journal:  Expert Opin Ther Targets       Date:  2010-11-20       Impact factor: 6.902

2.  A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene.

Authors:  Nakhle Saba; Hana Safah
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

3.  Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.

Authors:  S A Pileri; S Ascani; M C Cox; C Campidelli; F Bacci; M Piccioli; P P Piccaluga; C Agostinelli; S Asioli; D Novero; M Bisceglia; M Ponzoni; A Gentile; P Rinaldi; V Franco; D Vincelli; A Pileri; R Gasbarra; B Falini; P L Zinzani; M Baccarani
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

4.  Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.

Authors:  Juliana Schwaab; Marcin Knut; Claudia Haferlach; Georgia Metzgeroth; Hans-Peter Horny; Andrew Chase; William Tapper; Joannah Score; Katherine Waghorn; Nicole Naumann; Mohamad Jawhar; Alice Fabarius; Wolf-Karsten Hofmann; Nicholas C P Cross; Andreas Reiter
Journal:  Ann Hematol       Date:  2014-09-27       Impact factor: 3.673

5.  The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.

Authors:  Marina Bousquet; Cathy Quelen; Véronique De Mas; Eliane Duchayne; Blandine Roquefeuil; Georges Delsol; Guy Laurent; Nicole Dastugue; Pierre Brousset
Journal:  Oncogene       Date:  2005-11-03       Impact factor: 9.867

6.  The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.

Authors:  Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.

Authors:  Verena Patterer; Susanne Schnittger; Wolfgang Kern; Torsten Haferlach; Claudia Haferlach
Journal:  Ann Hematol       Date:  2013-02-12       Impact factor: 3.673

Review 8.  Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?

Authors:  Barbara J Bain; Shahzaib Ahmad
Journal:  Br J Haematol       Date:  2014-06-10       Impact factor: 6.998
  8 in total
  3 in total

1.  PCM1-JAK2 Fusion in a Patient With Acute Myeloid Leukemia.

Authors:  Jong Mi Lee; Jaewoong Lee; Eunhee Han; Myungshin Kim; Yonggoo Kim; Kyungja Han; Hee Je Kim
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

2.  Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia.

Authors:  Giuliana Rizzuto; Matteo Leoncin; Silvia Imbergamo; Daniela Taurino; Maria Caterina Mico; Manuela Tosi; Anna Michelato; Ksenija Buklijas; Orietta Spinelli; Federico Lussana; Federica Lessi; Marco Pizzi; Laura Bonaldi; Gianni Binotto; Alessandro Rambaldi; Carmela Gurrieri
Journal:  Clin Case Rep       Date:  2022-01-07

3.  PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.

Authors:  Henry G Kaplan; Ruyun Jin; Carlo B Bifulco; James M Scanlan; David R Corwin
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.